The R249Q amino acid replacement has been introduced into a genomic fragment containing the Mhc transcription unit. The equivalent amino acid change is associated with hypertrophic cardiomyopathy in humans.
GT16770924AG
CGT>CAG
R248Q | Mhc-PA; R248Q | Mhc-PB; R248Q | Mhc-PC; R248Q | Mhc-PD; R248Q | Mhc-PE; R248Q | Mhc-PF; R248Q | Mhc-PG; R248Q | Mhc-PH; R248Q | Mhc-PI; R248Q | Mhc-PK; R248Q | Mhc-PL; R248Q | Mhc-PM; R248Q | Mhc-PN; R248Q | Mhc-PO; R248Q | Mhc-PP; R248Q | Mhc-PQ; R248Q | Mhc-PR; R248Q | Mhc-PS; R248Q | Mhc-PT; R248Q | Mhc-PU; R248Q | Mhc-PV
R249Q
Analogous R249Q mutation in human MYH7 implicated in hypertrophic cardiomyopathy; mutation carried on in vitro construct.
The overall morphology of DLM fibers in MhcR249Q/MhcR249Q, Mhc10/Mhc10 and MhcR249Q/+, Mhc10/Mhc10 adults is comparable to controls. At the ultrastructure level, MhcR249Q/MhcR249Q, Mhc10/Mhc10 individuals show no defects in late pupae and in 2h-old adults, but 2 days-old adults show minor degradation of the hexagonal packing around the fibre edges and 7 days-old adults show severe fiber disruption; MhcR249Q/+, Mhc10/Mhc10 individuals show no obvious defects.
In both MhcR249Q/MhcR249Q, Mhc10/Mhc10 and MhcR249Q/+, Mhc10/Mhc10 adults, these indirect flight muscles have altered kinetics, including significant decreases in active tension, power generation and net work, but unaltered passive tension, as compared to controls. MhcR249Q/MhcR249Q, Mhc10/Mhc10 adults, but not MhcR249Q/+, Mhc10/Mhc10 adults show significantly altered cross-bridge kinetics, including decreased maximum frequency of muscle length oscillation, increased 2πc and decreased 2πb.